Spring Genetics Overview
- Founded
- 2009
- Status
- Acquired/Merged
- Employees
- 9
- Latest Deal Type
- Series B
- Latest Deal Amount
- $2M
- Investors
- 1
Spring Genetics General Information
Description
Operator of an aquatic breeding company dedicated to the genetic improvement of Nile Tilapia supporting the sustainable development of global aquaculture. The company is developing the genetic material used in salmon production world wide, as well as for the GIFT material for Tilapia in Asia, thereby providing cleints with consulting, research and development services on selective breeding programs for aquaculture species.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Office
- 21200 SouthWest 177 Avenue
- Miami, FL 33187
- United States
+1 (305) 000-0000
Spring Genetics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 10-Aug-2020 | $2M | 000 | Completed | Generating Revenue/Not Profitable | |
| 1. Merger/Acquisition | 27-Jul-2015 | 00.00 | 00.000 | Completed | Generating Revenue/Not Profitable |
Spring Genetics Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Morten Rye | Managing Director | ||
| Jose Ospina | Manager, Production |
Spring Genetics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial